News that has caught Rachael Babin’s eye this week
Browsing: Editor’s Choice
Rutgers scientist creates ‘virtual biopsy’ device to detect skin tumours
Using sound vibrations and pulses of near-infrared light, a Rutgers University scientist has developed a…
Triple-negative breast cancer among black women in the US varies by birthplace
A new study finds substantial variation in the prevalence of triple-negative breast cancer among black…
ASCO 2019: Cleveland researchers test novel gene therapy for glioblastoma
A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and the Case…
ASCO 2019: Suggested benefit in PCV chemoradiotherapy for both IDH-mutant WHO-defined molecular subgroups
A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase…
ASCO 2019: Men who choose active surveillance for early prostate cancer often don’t follow monitoring rules
Preliminary results from a University of North Carolina Lineberger Comprehensive Cancer Center study found that…
ASCO 2019: Adding enzalutamide to standard first-line treatment improves survival for men with metastatic hormone-sensitive prostate cancer
An interim analysis of the international randomised, phase III ENZAMET trial found that 80% of…
ASCO 2019: Entrectinib gets edge over crizotinib against ROS1 lung cancer
Crizotinib and entrectinib are both active against ROS1 non-small cell lung cancer. But which is…
ASCO 2019: Front-line pembrolizumab is promising alternative to chemotherapy for advanced gastroesophageal junction and gastric cancers
The KEYNOTE-062 phase III randomised clinical trial achieved its primary endpoint, showing that for patients…
ASCO 2019: Delays lead to late-stage diagnosis of young people with colorectal cancer
The incidence of early onset colorectal cancer has increased nearly 50 percent in the last…
Towards a safer treatment for leukaemia
An international team of researchers at VIB-KU Leuven, Belgium, the UK Dementia Institute and the…